Cropsolution will use selected portions of Norak's compound library in their agrochemical discovery program

Norak Biosciences, Inc. announced today the signing of an agreement with Cropsolution, Inc. for purchase of selected subsets of Norak's small molecule, compound library. Norak has assembled a compound library of over 900,000 drug-like, small molecules and is actively screening these compounds in its G protein-coupled receptor (GPCR)-based drug discovery program. Cropsolution will utilize the selected compounds in its agriculture discovery program.

Cropsolution is an agricultural biotechnology company focused on the discovery and development of innovative chemical products for the crop protection market. Norak Biosciences is a biopharmaceutical company utilizing its proprietary Transfluor® technology to discover GPCR-based drugs. Norak's Transfluor® technology is a patented, universal GPCR drug discovery technology designed to be the most direct and accurate method for screening potential drug candidates against GPCR targets, whether known or orphan.

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor® technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors.